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Phosphoinositide-specific phospholipase C (PLC) is a central effec-
tor for many biological responses regulated by G-protein–coupled
receptors including Drosophila phototransduction where light sen-
sitive channels are activated downstream of NORPA, a PLC ho-
molog. Here we show that the sphingolipid biosynthetic enzyme,
ceramide kinase, is a novel regulator of PLC signaling and photo-
receptor homeostasis. A mutation in ceramide kinase specifically
leads to proteolysis of NORPA, consequent loss of PLC activity, and
failure in light signal transduction. The mutant photoreceptors also
undergo activity-dependent degeneration. Furthermore, we show
that a significant increase in ceramide, resulting from lack of
ceramide kinase, perturbs the membrane microenvironment of
phosphatidylinositol 4, 5, bisphosphate (PIP2), altering its distribu-
tion. Fluorescence image correlation spectroscopic studies on
model membranes suggest that an increase in ceramide decreases
clustering of PIP2 and its partitioning into ordered membrane
domains. Thus ceramide kinase–mediated maintenance of cer-
amide level is important for the local regulation of PIP2 and PLC
during phototransduction.
Signal transduction via G-protein–coupled receptors (GPCRs) isvital for many cellular processes including vision, olfaction,
taste, and neurotransmission. Extensive studies on proteins consti-
tuting this family and their interactions reveal complex signaling
networks regulated at multiple levels (1). Lipids play equally
important roles in GPCR signaling, as most of the signal transduc-
tion machinery is membrane associated. How lipids regulate GPCR
signaling is being addressed in recent years (2). Our current
knowledge of how lipids influence each other to form membrane
microenvironments and how this modulates proteins during signal
transduction in a multicellular organism is limited. In this study, we
address this issue in the context of Drosophila phototransduction, a
prototypic G-protein–coupled phosphoinositide cascade, by genet-
ically modulating the sphingolipid ceramide.
Analyses of Drosophila phototransduction have led to the
identification, characterization, and regulation of many signaling
components (3). Phototransduction begins with the absorption
of light by rhodopsin, followed by the activation of a G protein
(Gq). Gq activates the critical effector NORPA, a phospho-
lipase C (PLC) that catalyzes the hydrolysis of phosphatidylino-
sitol 4, 5-bisphosphate (PIP2) into two important second mes-
sengers, diacylglycerol and inositol 1, 4, 5-trisphosphate.
Activation of PLC leads to gating of two transduction channels,
transient receptor potential (TRP) and TRP-like. Although
many of the proteins involved in phototransduction have been
well characterized, we are only beginning to understand how
lipids and enzymes involved in lipid metabolism regulate this
cascade (4–7). Sphingolipids are integral components of all
eukaryotic cell membranes and also act as second messengers in
diverse signaling pathways (8). The sphingolipid biosynthetic
pathway is an evolutionarily conserved route that generates and
interconverts various sphingolipids such as ceramide, sphin-
gosine, ceramide 1–phosphate and sphingosine 1–phosphate (9).
We showed earlier that modulating this biosynthetic pathway by
targeted overexpression of Drosophila neutral ceramidase
(CDase), an enzyme that converts ceramide to sphingosine,
rescues retinal degeneration in an arrestin mutant, and facilitates
membrane turnover in a rhodopsin null mutant by modulating
the endocytic machinery (10–12). Although these studies estab-
lished that ceramide metabolism is important for survival of
photoreceptors, they did not evaluate its role in signaling events
during phototransduction.
Ceramide kinase (CERK), a recently cloned lipid kinase, phos-
phorylates ceramide to ceramide 1–phosphate (C-1-P), thereby
decreasing ceramide levels (13, 14). Here we show that Drosophila
ceramide kinase (DCERK) regulates PLC activity, function, and
the local organization of PIP2 in GPCR signaling by controlling the
ceramide level. Genetic, biochemical, and electrophysiological
analyses of DCERK deficient flies reveal a severe down regulation
of NORPA and failure in phototransduction. Increased ceramide
levels in the mutant also alter the level and membrane microenvi-
ronment of PIP2 that correlates with a failure of NORPA to localize
to the membranes. Using fluorescence image correlation spectros-
copy in supported bilayers, we show that ceramide perturbs both the
protein-dependent and -independent compartmentalization of
PIP2, thus providing a biophysical basis for the effect of ceramide
on PIP2. These findings show that sphingolipids and phospholipids
cooperate in vivo to establish a suitable membrane microenviron-
ment for signaling mediated by PLC.
Results
Identification and Characterization of Drosophila CERK (DCERK). A
BLAST search of the Drosophila melanogaster genome identified
CG16708 as the Drosophila homolog of the CERK gene and was
named DCERK. DCERK is on the right arm of the third chro-
mosome at 82F11–83A1. It encodes a protein of 687 aa and is 35%
identical to human CERK (Supporting Information (SI) Fig. S1).
Western analyses using monoclonal antibodies raised against
DCERK protein showed that it is expressed during all develop-
mental stages (Fig. S2A). Membrane association analyses showed
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that DCERK is an integral membrane protein that is released from
membranes by detergent treatment (Fig. S2B). Hydrophobicity
analysis predicts two transmembrane helices (residues 258–282 and
515–533) in the protein. Immunofluorescence analyses of Schnei-
der cells and third-instar larval wing discs using DCERK antibodies
showed that the protein predominantly localized to the plasma
membrane (Figs. 1A, S2 C and D). Like the mammalian enzyme,
DCERK has a diacylglycerol kinase domain and a Ca2/calmodulin
binding domain. The N terminus of mammalian CERK contains a
pleckstrin homology (PH) domain that binds PIP2 and targets
CERK to the membrane. Although primary sequence comparisons
of DCERK do not reveal a PH domain except for a conserved
tryptophan residue, secondary structure predictions indicate that
DCERK has a noncanonical PH domain. We confirmed that
DCERK could phosphorylate ceramide by establishing stable cells
expressing tagged DCERK or control vector and measuring en-
zyme activity in membrane fractions by a chemiluminescence assay
that measures ATP depletion (15). DCERK used ceramide but not
sphingosine or diacylglycerol as a substrate (Fig. S3 A and B).
Sphingolipid enriched fractions were prepared from stable cells
expressing DCERK and ceramide and C-1-P levels were measured
by ultraperformance liquid chromatography in conjunction with
mass spectrometry (UPLC-MS/MS). The analyses confirmed that
ceramide kinase overexpression increased C-1-P and decreased
ceramide level (Fig. S3C).
dcerk1 Mutant Undergoes Light-Dependent Photoreceptor Degener-
ation. To understand how CERK regulates ceramide metabolism in
vivo and, in particular, to analyze whether it regulates photorecep-
tor structure and function, we generated mutants in DCERK. Two
P element lines (CG16708BG01100 and P{EPgy2}EY07850) inserted
in the DCERK gene were identified in Fly Base. Because both lines
expressed significant amounts of DCERK protein, we excised the
P element CG16708BG01100 (inserted in the first intron) using
standard techniques. The genetic scheme used to mobilize it is
described in Fig. S4A. A total of 640 independent excision lines
were established of which 57 were lethal. The lethal lines were
analyzed by transgenic rescue using a wild-type copy of DCERK,
whereas the viable lines were analyzed by western analysis for
decrease or lack of DCERK protein. This led to the isolation of
dcerk1 mutant, and western analysis of dcerk1 fly head extracts
showed less than 2% intact protein compared with control level
(Fig. 1B). Reverse transcription–polymerase chain reaction (RT-
PCR) analysis of dcerk1 showed a significant reduction in the
DCERK transcript level (Fig. 1C). PCR analysis suggested that 6
kb of the original P element left behind affected the DCERK
transcript level (Fig. S4B). The above data show that dcerk1 is a
severe hypomorphic mutant of DCERK. dcerk1 Flies are semilethal,
and show fertility defects. All of the phenotypes were rescued by the
introduction of a DCERK transgene into dcerk1.
Because our earlier published results indicated that ceramide is
an important regulator of photoreceptor viability, we analyzed
photoreceptors of dcerk1 for possible defects. As seen in Fig. 1E,
dcerk1 showed severe photoreceptor degeneration, cells appeared
vacuolated with almost no intact rhabdomeres. A time course
depicting progressive degeneration of the photoreceptors is shown
in Fig. S4C. The degenerative phenotype was rescued by introduc-
ing a transgene expressing DCERK (Fig. 1F). Degeneration of
dcerk1 depended on light activation of phototransduction, as pho-
toreceptors of dark raised flies did not show morphological signs of
degeneration (Fig. 1G).
dcerk1 Mutant Does Not Respond to Light, and Its PLC Level and
Activity Are Severely Downregulated. To test whether photoreceptor
function was also defective in dcerk1, we performed electroretino-
gram recordings (ERGs) from control, mutant, and rescued flies
raised in the dark. Surprisingly, despite their intact morphology,
mutants did not respond to the light stimulus (Fig. 2A). However
dcerk1 rescued with a DCERK transgene showed normal ERGs
(Fig. 2 A and B). The lack of light response in dcerk1 retina suggested
that CERK regulates a crucial step in phototransduction. Mutations
in NORPA, the critical effector of phototransduction, led to
defective light-induced electrical responses, with null mutants being
blind (16–18). Because dcerk1 were blind, we checked the steady-
state level of NORPA by immunoblotting using 1-day-old dcerk1
maintained in the dark. We observed that NORPA protein was
absent in dcerk1 and that the expression of a DCERK transgene in
the mutant rescued the NORPA level (Fig. 2C). In overexposed
blots, a small amount of NORPA can be detected in 1-day-old flies
(Fig. S5C). Real-time PCR analysis revealed that the amount of
NORPA transcript was not different between w1118 and dcerk1,
suggesting that DCERK primarily regulates NORPA posttranscrip-
tionally (Fig. S5D). Although w1118 retinal extracts showed high
PLC activity, mutant extracts lacked this activity, and it was restored
in the rescued flies (Fig. 2D). Our results thus far show that the lack
of DCERK downregulates NORPA and that this results in loss of
its activity and function in photoreceptor cells.
Localization and Levels of Other Phototransduction Components Are
Not Affected in dcerk1 Mutant. In Drosophila photoreceptors, INAD,
a scaffolding protein, organizes signaling components including
NORPA into a supramolecular complex to maximize the efficiency
of phototransduction (19, 20). We tested whether DCERK specif-
ically influenced NORPA or if it could affect the concentration or
localization of other signaling components by western and immu-
nofluorescence analyses. As seen in Fig. S6 A and B, no significant
difference was observed between control and dcerk1 for any of the
Fig. 1. dcerk1 Is a severe hypomorph showing light-dependent photoreceptor
degeneration. (A) Immunostaining of Schneider cells with antibodies to DCERK
and N-cadherin, a plasma membrane marker. DCERK shows plasma membrane
staining. (B) Western blot analysis of one, three, and five head extracts (1 h, 3 h,
and 5 h) from w1118 and dcerk1 with DCERK antibody (3H7) reveals less than 2%
DCERK protein in the mutant lanes. The blot is probed with an antibody to
inositol polyphosphate 1–phosphatase (IPP) as a loading control. (C) RT-PCR
analysis shows significant reduction in DCERK transcript in dcerk1. Reactions with
actin serve as a control. Transmission electron micrographs (TEM) showing pho-
toreceptors of 5-day-old (D) w1118 (E) dcerk1 with extensive degeneration, (F)
DCERK transgene in dcerk1 showing degeneration is rescued, and (G) dark-raised
dcerk1 showing no significant degeneration. Bars, 2 m.
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proteins tested in 1-day-old flies. Immunostaining with a NORPA
antibody revealed that its level was too low to be detected (Fig.
S6B). By day 14, dark-raised dcerk1 showed loss of TRP (Fig. S6C).
Fig. S6D shows immunostaining of eyes with antibodies to DCERK
and Rh1 in w1118 and dcerk1. In these sections, CERK is present in
rhabdomeres and other membranous compartments of photore-
ceptors, overlying cone, and lens cells, whereas Rh1 shows specific
rhabdomere staining of R1–R6 cells. That CERK can localize to
rhabdomeres is also seen in thin sections of photoreceptors co-
stained with antibodies to DCERK and INAD (Fig. S7A).
DCERK Regulates NORPA and Photoreceptor Function by Modulating
the Ceramide Level. To test whether the substrate, ceramide, or the
product C-1-P was responsible for regulating NORPA, we mea-
sured their levels in lipid extracts from control and dcerk1 by
UPLC-MS/MS. The mutant flies showed a 250–300% increase in
ceramide levels in all of the species measured and a modest
decrease (40%) in C-1-P levels when compared with w1118 (Fig. 3A).
The levels of other sphingolipids such as ceramide phosphoethano-
lamine and glucosyl ceramide did not change significantly (30%)
between w1118 and dcerk1 extracts. It is likely that other pathways or
proteins could contribute to the synthesis of C-1-P, as it is decreased
by only 40% in the mutant. To determine whether the significant
increase in ceramide level in dcerk1 was crucial for downregulating
NORPA, we overexpressed CDase in dcerk1. CDase overexpression
decreases the ceramide level by catalyzing the hydrolysis of cer-
amide to sphingosine and a fatty acid (10). Targeted overexpression
of CDase in dcerk1 photoreceptors rescued NORPA, suggesting
that an increase in ceramide contributed to a decrease in NORPA
level (Fig. 3 B and C). Lipid extracts from dcerk flies expressing
CDase indeed showed a decrease in ceramide in all species mea-
sured except C-20 (Fig. S7B). ERGs carried out on dcerk1 express-
ing CDase showed that overexpression of CDase rescues the lack of
light response observed in dcerk1 (Fig. 3D). CDase expression also
rescued the retinal degeneration in dcerk1 (Fig. 3E).
Ceramide Levels Regulate the Localization and Level of PIP2. Because
PLC acts on PIP2, its localization and function is modulated by the
lipid bilayer (21). We evaluated whether an increase in ceramide
could alter global membrane properties such as bilayer fluidity. We
measured fluorescence polarization as a measure of membrane
fluidity, and these experiments showed that membrane fluidity did
not change significantly in dcerk1 (22, Fig. S7C). As bulk membrane
properties like fluidity were not affected, we decided to test whether
the membrane microenvironment was perturbed in dcerk1 due to an
increase in ceramide concentration. Because conventional proce-
dures that involve 3Hinositol labeling followed by HPLC separation
of radiolabeled phosphoinositides could not be adapted to flies, we
measured the PIP2 level in control and dcerk1 by standardizing a
coupled nonradioactive TLC separation of phosphoinositides fol-
lowed by an enzyme-linked immunosorbent assay (ELISA) using a
monoclonal antibody that recognizes PIP2 with high specificity (23).
dcerk1 showed a 60% increase in the PIP2 level compared with the
control (Fig. 4A). NORPA null mutants lacking the major PLC
used as a control showed an accumulation of PIP2. We then
analyzed whether increased ceramide could affect the distribution
of PIP2 using the PIP2 antibody in thin sections of control and dcerk1
mutant photoreceptor cells. As seen in Fig. 4B (labeled PIP2), PIP2
appeared to be enriched in doughnut-shaped clusters and spots at
the rhabdomeres and their base. We then confirmed that these
clusters recruit PLC by expressing PLC1PH-GFP in photorecep-
tors and staining thin sections of photoreceptors with a GFP
antibody. In this widely used tool to visualize the distribution of
PIP2, the PH domain of PLC1, which specifically binds to PIP2 at
the plasma membrane, is fused to GFP (24). As seen in Fig. 4B
(labeled GFP), in addition to rhabdomere staining, clusters were
visible at the membrane. The plasma membrane was stained with
cadherin in these sections (labeled Cadherin). Fig. 4B (labeled
PIP2GFP) shows the overlay of PIP2 and GFP, suggesting that
PLC can co-localize to PIP2 enriched clusters at the membrane.
To test whether clustering is unique to PIP2, we also expressed
the PH domain of general receptor for phosphoinositides-1
Fig. 2. Severe downregulation of NORPA expression in dcerk1 flies renders
them unresponsive to light. (A) ERG recordings from dark-raised w1118, dcerk1,
and rescued flies. The dcerk1 do not respond to light, whereas rescued flies
exhibit robust response. Cn bw flies were also used as control, as the rescued
flies were in cn bw background. (B) Quantitative analysis of ERG recordings
shows that the amplitude in the rescued flies is comparable to that in control
flies. (C) Western blot of head extracts probed with NORPA antibody shows
that its expression is severely reduced in dcerk1 and rescued in dcerk1 express-
ing DCERK transgene. (D) Retinal extracts of dcerk1 do not show PLC activity,
whereas activity of rescued flies is comparable to that of w1118. Error bars
denote standard deviation (n  3).
Fig. 3. dcerk mutant accumulates ceramide, and reducing the ceramide level
restores NORPA expression and function. (A) Total lipids extracted from dcerk1
and w1118 flies are subjected to UPLC-MS/MS. Individual ceramide and ceramide
1–phosphate species (with tetradecasphinganine backbone to which 18–, 20–,
22–, or 24–carbon chain fatty acids are attached) are measured and values are
calculated for dcerk1 relative to w1118. (B) Expression of ceramidase (CDase)
transgene rescues NORPA expression in dcerk1. (C) Quantification of NORPA
shows that the level is comparable in the CDase dcerk1 rescued flies compared
with the control. (D) ERGs showing CDase transgene rescues light response in
dcerk1. (E) CDase overexpression rescues retinal degeneration in dcerk1.








(GRP1) fused to GFP which binds specifically to phosphatidyl-
inositol-3,4,5 -P3(PIP3). As seen in Fig. 4C, punctate dots of PIP3
staining can be seen at the rhabdomeres and their base but big
clusters seen with PIP2 are absent here. To analyze the distri-
bution of PIP2 in dcerk1, thin sections of photoreceptors were
stained with PIP2 antibody. Unlike w1118, PIP2 was not clustered
but fragmented in dcerk1 and staining was diffuse (Fig. 4D and
Fig. S7D). The diffuse staining in the mutant is better appreci-
ated in experiments using quantum dot conjugated secondary
antibody (Fig. S8A). norpA null mutant photoreceptors stained
with PIP2 antibody showed PIP2 clusters (Fig. 4D and Fig. S8A).
The ceramide level in norpA mutant would be unaltered and the
microenvironment likely to be unperturbed. Morphometric anal-
yses showed there were six to eight PIP2 clusters in w1118 and
norpA null mutant ommatidium, whereas there were two to three
in dcerk1 (Fig. S7E). Our results suggest an increase in the
ceramide level disrupts the organization of PIP2-enriched areas
at the plasma membrane.
NORPA That Is Not Membrane Associated Is Not Functional and Is
Targeted for Degradation. As the interaction of PLC with its
substrate PIP2 requires membrane association, and as PIP2 orga-
nization is affected in dcerk1, we examined the membrane associ-
ation of NORPA in dcerk1. We tested whether reducing ubiquitin-
mediated proteosomal degradation in vivo would allow us to detect
NORPA in dcerk1. We used a dominant temperature-sensitive
(DTS) mutation, DTS5, that affects the 6 proteosomal subunit
(25). If NORPA is targeted for degradation in dcerk1, then express-
ing DTS5 in dcerk1 photoreceptors should result in restoration of
NORPA. As seen in Fig. 5A, this was indeed the case; quantitative
analysis of NORPA levels is shown in Fig. S8B. We fractionated
head extracts from control and dcerk1 expressing the DTS5 subunit
into pellet and supernatant fractions and looked for NORPA by
western analysis. These studies showed that in control almost all of
the NORPA fractionates with the pellet underscoring its membrane
localization, whereas most of the NORPA in dcerk expressing DTS5
was in the soluble fraction and hence cytosolic. To test whether this
NORPA was functional, ERGs were carried out on dcerk1 express-
ing DTS5. Whereas DTS5 flies showed a light response, DTS5 flies
in dcerk1 showed no response (Fig. 5C). Photoreceptor degenera-
tion in dcerk1 could also not be rescued in these flies (Fig. 5D).
Taken together, a likely explanation for our results is that NORPA
that is not membrane associated because of the disorganization of
PIP2 is unstable and is targeted for degradation.
Ceramide Affects PIP2 Clustering and Its Partitioning into Liquid
Ordered Membrane Domains. Cellular membranes are not homoge-
neous but compartmentalized into liquid ordered (Lo), liquid
disordered (Ld), and gel (L) phases. In the Ld phase, lipids diffuse
freely, while in the L phase they are immobile and the Lo phase is
an intermediate stage. The existence of PIP2 compartmentalization
in vivo has been rationalized by two hypotheses: (i) PIP2 molecules
can cluster independent of proteins or other lipids, for example,
through hydrogen bonding between their head groups; or (ii) PIP2
can be laterally sequestered by certain proteins such as MARCKS,
GAP43 into cholesterol-rich membrane domains (26). We explored
each of these scenarios in model membranes with defined compo-
nents to understand how ceramide accumulation could influence
PIP2. To address protein-independent clustering, we prepared Ld
supported bilayers made of dioleoylphosphatidylcholine (DOPC),
3% molar brain PIP2, and a trace amount of fluorescent PIP2
(BodTMRPIP2) for visualization. Under these conditions, BodT-
MRPIP2 forms clusters that can be visualized using fluorescence
Fig. 4. Increased ceramide level alters PIP2 membrane
microenvironment in dcerk1. (A) The PIP2 level is ele-
vated in dcerk1 compared with w1118. (B) Immunostain-
ing of photoreceptors expressing PLCPH GFP in w1118
cn bw background with PIP2, GFP and cadherin anti-
bodies. PIP2 clustering can be seen at the membranes,
and the overlay shows that PLCPH GFP localizes to
these clusters. A cartoon of the staining shows PIP2 in
green, GFP in red, and overlay in yellow. Purple rhab-
domeres are from overlay of cadherin in blue and GFP
in red. (C) Immunostaining of photoreceptors express-
ing GRP1PH GFP in w1118 cn bw background with GFP
and cadherin antibodies. PIP3 staining, unlike PIP2, is
not in large clusters. Last panel is a magnified view of
one ommatidium; arrows show small dots of PIP3 in the
rhabdomere vicinity. (D) PIP2 is disorganized in dcerk1.
Photoreceptors of w1118, dcerk1 and norp A null are
immunostained with PIP2 antibody. The w1118 and norp
A null photoreceptors show PIP2 staining in clusters,
which are less in dcerk1.
Fig. 5. NORPA is unable to bind efficiently to membranes in dcerk1 and is
degraded. (A) NORPA expression is detected in western analysis of dcerk1
expressing DTS5. Lanes 1: w1118; lane 2: dcerk1; lane 3: UAS-DTS5;dcerk1; lane
4: GMR-Gal4;dcerk1; and lane 5: GMR-Gal4/UAS-DTS5;dcerk1. (B) NORPA is
unable to bind to membranes in dcerk1. Fractionation experiments on head
extracts from dcerk1 expressing DTS5 subunit in photoreceptors (1) and con-
trol DTS5 subunit (2) show that a significant fraction of NORPA is soluble in
dcerk1 expressing DTS5, whereas it is in the pellet fraction in the control
extract. (C) Amplitude values from ERGs show that DTS5 flies in dcerk1 show
no light response, indicating NORPA is not functional. (D) Ultrastructure of
photoreceptors expressing DTS5 in dcerk1 still degenerate.
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laser scanning microscopy (Fig. 6). Fluorescence correlation spec-
troscopy was used to show that membrane fluidity is not affected
by the presence of the clusters (Fig. S8C). It was recently shown that
in free-standing membranes, PIP2 forms similar clusters that de-
pend on the presence of divalent cations such as Ca2 (27). Next,
we evaluated the effects of incorporating ceramides in these prep-
arations on the clustering and distribution of PIP2, and image
correlation spectroscopic (ICS) analysis was performed to quantify
the degree of PIP2 clustering (Fig. 6G). The spatial segregation of
BodTMRPIP2 depends on the presence of brain PIP2 in the lipid
mixture, as simple DOPC samples show no significant heteroge-
neities (Fig. 6A). The incorporation of either brain ceramide or
short-chain C6 ceramide significantly decreases cluster formation
(Fig. 6E and F). C-1-P does not prevent PIP2 clustering, whereas
cholesterol seems to promote it (Fig. 6C and D). From these
experiments, it appears that the presence of ceramide has a direct
effect on the clustering of PIP2 in model membranes. A possible
explanation for this phenomenon lies in the peculiar biophysical
properties of the ceramide molecule. Ceramide has a small polar
head (like cholesterol), and it is both donor and acceptor for
hydrogen bonding (28). The former feature might explain why
ceramide and cholesterol interact with PIP2: the energetically
unfavorable contact between water and their hydrophobic moieties
are avoided by the large PIP2 polar head (‘‘umbrella effect’’) (29).
Nevertheless, the distinctive structural properties of ceramide (e.g.,
the amidic group that is absent in cholesterol and phospholipids)
could influence the hydrogen bond network of surrounding
molecules. Ceramide might act as a local chaotrope that perturbs
the PIP2–water–hydrogen bond network, thus allowing the
electrostatic repulsion between PIP2 molecules to disperse the
clusters (30).
Protein/lipid dependent PIP2 clusters (scenario 2): A second line
of thought regarding PIP2 compartmentalization is that certain
proteins, for example, the diacylated protein GAP-43, can bind
PIP2 and partition into small raft domains, thus offering a molecular
basis for PIP2 segregation (31). In this context, ceramide might play
an important role inducing structural alterations in the lateral
organization of the membrane bilayer. Nonphosphorylated long-
chain ceramides can form specific membrane microdomains that
can exist in gel phase (L) within raft domains of Lo phase (32).
Such ceramide-rich domains are characterized by very tight lipid
packing. To test whether such lateral segregation properties of
ceramide within membrane bilayers could explain the loss of PIP2
aggregation seen in vivo in CERK mutants, we examined the effect
of increasing ceramide on PIP2 organization in supported bilayer
showing raft-like phase separation. BodTMRPIP2 was added to the
lipid mixture in trace amounts to study the organization of PIP2,
whereas a green fluorescent lipid analog (BodChol) was used as a
marker for the Ld phase. In these preparations, PIP2 localizes to the
Ld phase of the membranes (Fig. 6H) because of the multiple
unsaturation in the sn-2 hydrocarbon chain that would make PIP2
partitioning into tightly packed domains energetically unfavorable.
In this set of experiments, we monitored PIP2 partition into ordered
domains, either raft-like or ceramide-rich, as this could be a more
relevant mechanism for PIP2 segregation in vivo, and we did not
focus on the Ca2 dependent PIP2 clustering only partially observ-
able in the Ld phase because of washing with 15 mM ethylenedia-
minetetraacetic acid (EDTA). Following a published protocol (31),
we verified that the addition of doubly palmitoylated peptide
GAP-43P (i.e., the N terminus plus the basic effector domains of
GAP-43) relocates a portion of the PIP2 to the Lo (raft-like) phase
of the membrane (Fig. 6I). Substitution of 50% of sphingomyelin
with ceramide results in bilayers containing ceramide-rich domains
in a matrix of Ld phase. Here again, PIP2 is localized to the Ld phase
(Fig. 6J). Interestingly, the addition of the acylated GAP-43P
showed no significant change in the dimension of the ordered
domains (Fig. 6K). Furthermore, very little of the PIP2 relocates to
these ceramide rich domains. Figure 6L shows quantification of the
Fig. 6. Ceramide affects protein-inde-
pendent PIP2 clustering and GAP-43P–
induced PIP2 partition in ordered do-
mains. Fluorescence images of
BodTMRPIP2 (0.005% mol) in supported
bilayers containing (A) DOPC, (B) DOPC 
3% BrPIP2, (C) B  5% Cer-1-P, (D) B  5%
cholesterol, (E) B  5% C6 ceramide, and
(F) B  5% brain ceramide at room tem-
perature. The presence of ceramide af-
fects clustering of PIP2. (G) Degree of clus-
tering of PIP2 for all samples described
above. This quantity is defined as inverse
of the cluster density, as calculated via ICS
on an average of eight 23  23-m2 im-
ages for each sample. *E and F are statis-
tically distinguishable from B with P 
0.01. **D is statistically distinguishable
from B with P  0.1. (H) Fluorescence
image of a supported bilayer showing Lo
domains in Ld phase. Red color refers to
BodTMRPIP2 and green to BodChol
(0.01% mol). The Lo domains appear dark
in both channels. (I) When the bilayer is
treated with palmitoylated GAP-43P, the
Lo domains are fragmented and show a
significant degree of fluorescence in the
red channel. (J and K) Analogous imaging
of bilayers with ceramide-rich domains in
Ld phase, without and with GAP-43P re-
spectively. Ceramide-rich domains are
dark in both channels. (L) Partition of
BodTMRPIP2 in Lo or ceramide-rich domains. This is calculated as the ratio between the average red signal in Lo (or ceramide) domains— dark in the green
channel and the signal in the Ld phase— bright in the green channel. *I is statistically distinguishable from H with P  0.01 and **K is statistically
indistinguishable from sample J with P  0.3. (Scale bars, 2 m.)








fluorescent intensity originating from PIP2 in the ordered domains
compared with that from PIP2 in the disordered phase. These
experiments suggest where PIP2 clustering in vivo is determined by
the partition of this lipid into small protein/lipid domains, the
accumulation of ceramide, and the formation of highly ordered,
ceramide-rich domains could effectively decrease PIP2 segregation.
The conclusions drawn from fluorescence experiments described
above correlate well with the observed effects of increased cer-
amide in DCERK mutants on PIP2 organization in photoreceptor
cells.
Discussion
In this study, we show that DCERK regulates the ceramide level to
maintain PLC and membrane organization of PIP2 during phos-
phoinositide-mediated GPCR signaling in Drosophila. Our results
are summarized in a model depicted in Fig. S9. Morphometric
analysis of PIP2 clusters suggests that there are still some clusters in
dcerk1; thus, the loss of NORPA in dcerk mutant may not be due
only to the loss of PIP2 clustering. Although the effect of ceramide
on PIP2 is central, increased ceramide could affect other membrane
properties that can downregulate NORPA or other proteins. Also,
INAD is required for localization of NORPA and TRP is required
for localization of INAD (20). Because TRP protein is affected over
time in dcerk1, additional interactions mediated by INAD and TRP
could also contribute to NORPA stability. Photoreceptor degen-
eration seen in cerk mutants is also not simply caused by loss of
NORPA protein, as it is more severe and sets in earlier than in
norpA null mutants. There could be other effects of ceramide
contributing to degeneration.
Recent clinical studies have identified mutations in the human
ceramide kinase like (CERKL) gene in patients with autosomal
recessive retinitis pigmentosa (33). No CERKL homolog has been
identified in the Drosophila genome. Interestingly, DCERK shares
31% identity with human CERKL (Fig. S1), and possibly DCERK
could perform some CERKL functions also. It would be worthwhile
to test whether CERK regulates PLC4, the closest homolog of
NORPA among mammalian PLCs, thereby participating in the
mammalian visual process. Recent analyses of cerk/ mice re-
vealed that CERK could function in cerebellar Purkinje cells (which
are also enriched in PLC4) and in neutrophil homeostasis (34, 35).
Because the mechanism by which mammalian CERK regulates
these processes is not known, it would be interesting to test whether
these functions are also mediated through PLC. Although our
current understanding limits a direct co-relationship between mam-
malian CERK and PLCs, it is likely that similar ceramide-regulated
microenvironments could operate in other phosphoinositide-
dependent signaling such as insulin signaling in adipocytes.
In summary, our data show that modulation of the ceramide level
by CERK regulates PIP2 and PLC function in Drosophila. Because
PIP2 and PLC are fundamental components of GPCR signaling,
uncovering their regulation by ceramide through CERK should
lead to a better understanding of lipid regulation in signaling.
Methods
Genetic Screen and Isolation of dcerk Mutants. The genetic scheme and method
to generate jump-out lines from DCERK P-element are outlined in SI Materials
and Methods. Five hypomorphic mutants including dcerk1 were obtained from
the screen.
Methods for electron microscopy and immunohistochemistry, assay for
ceramide kinase activity, estimation of sphingolipids by mass spectrometry
and PIP2 by ELISA, and model membrane experiments are described in detail
in SI Materials and Methods.
ACKNOWLEDGMENTS. We thank the Bloomington Stock Center, Indiana, Drs.
Andy Zelhof, and Eric Baerahcke for fly stocks. We thank Dr. Charles Zuker and
Ann Becker and Drs. Craig Montell, Hong-sheng Li, and John Sisson for their gifts
of antibodies. We thank Drs. Mike Czech and David Lambright for helpful
discussions. We thank Kathya Acharya for her work on the figures. Mr. Jun
Yonekubo (Nihon Waters K.K) is gratefully acknowledged for helpful discussions
andexperimental support.Thiswork is supportedbyNational InstitutesofHealth
grant R01EY16469 (to U.A.).
1. Marinissen MJ, Gutkind JS (2001) G-protein-coupled receptors and signaling networks:
Emerging paradigms. Trends Pharmacol Sci 22:368–376.
2. Escriba PV, Wedegaertner PB, Goni FM, Vogler O (2007) Lipid-protein interactions in
GPCR-associated signaling. Biochim Biophys Acta 1768:836–852.
3. Montell C (1999) Visual transduction in Drosophila. Annu Rev Cell Dev Biol 15:231–268.
4. Chyb S, Raghu P, Hardie RC (1999) Polyunsaturated fatty acids activate the Drosophila
light-sensitive channels TRP and TRPL. Nature 397:255–259.
5. LaLonde MM, et al. (2005) Regulation of phototransduction responsiveness and
retinal degeneration by a phospholipase D-generated signaling lipid. J Cell Biol
169:471– 479.
6. Huang FD, Matthies HJ, Speese SD, Smith MA, Broadie K (2004) Rolling blackout, a
newly identified PIP2-DAG pathway lipase required for Drosophila phototransduction.
Nat Neurosci 7:1070–1078.
7. Garcia-Murillas I, et al. (2006) lazaro encodes a lipid phosphate phosphohydrolase that
regulates phosphatidylinositol turnover during Drosophila phototransduction. Neu-
ron 49:533–546.
8. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: Lessons from
sphingolipids. Nat Rev Mol Cell Biol 9:139–150.
9. Acharya U, Acharya JK (2005) Enzymes of sphingolipid metabolism in Drosophila
melanogaster. Cell Mol Life Sci 62:128–142.
10. Acharya U, et al. (2003) Modulating sphingolipid biosynthetic pathway rescues pho-
toreceptor degeneration. Science 299:1740–1743.
11. Acharya U, Mowen MB, Nagashima K, Acharya JK (2004) Ceramidase expression
facilitates membrane turnover and endocytosis of rhodopsin in photoreceptors. Proc
Natl Acad Sci USA 101:1922–1926.
12. Acharya JK, et al. (2008) Cell-nonautonomous function of ceramidase in photoreceptor
homeostasis. Neuron 57:69–79.
13. Sugiura M, et al. (2002) Ceramide kinase, a novel lipid kinase. Molecular cloning and
functional characterization. J Biol Chem 277:23294–23300.
14. Wijesinghe DS, Lamour NF, Gomez-Munoz A, Chalfant CE (2007) Ceramide kinase and
ceramide-1-phosphate. Methods Enzymol 434:265–292.
15. Munagala N, et al. (2007) Identification of small molecule ceramide kinase inhibitors
using a homogeneous chemiluminescence high throughput assay. Assay Drug Dev
Technol 5:65–73.
16. Bloomquist BT, et al. (1988) Isolation of a putative phospholipase C gene of Drosophila,
norpA, and its role in phototransduction. Cell 54:723–733.
17. Pearn MT, Randall LL, Shortridge RD, Burg MG, Pak WL (1996) Molecular, biochemical,
and electrophysiological characterization of Drosophila norpA mutants. J Biol Chem
271:4937–4945.
18. Zhu L, McKay RR, Shortridge RD (1993) Tissue-specific expression of phospholipase C
encoded by the norpA gene of Drosophila melanogaster. J Biol Chem 268:15994–16001.
19. Mishra P, et al. (2007) Dynamic scaffolding in a G protein-coupled signaling system. Cell
131:80–92.
20. Tsunoda S, Zuker CS (1999) The organization of INAD-signaling complexes by a
multivalent PDZ domain protein in Drosophila photoreceptor cells ensures sensitivity
and speed of signaling. Cell Calcium 26:165–171.
21. Rebecchi MJ, Pentyala SN (2000) Structure, function, and control of phosphoinositide-
specific phospholipase C. Physiol Rev 80:1291–1335.
22. Rao RP, et al. (2007) Ceramide transfer protein function is essential for normal
oxidative stress response and lifespan. Proc Natl Acad Sci USA 104:11364 –11369.
23. Laux T, et al. (2000) GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal
rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol
149:1455–1472.
24. Varnai P, Balla T (1998) Visualization of phosphoinositides that bind pleckstrin homol-
ogy domains: Calcium- and agonist-induced dynamic changes and relationship to
myo-[3H]inositol-labeled phosphoinositide pools. J Cell Biol 143:501–510.
25. Belote JM, Fortier E (2002) Targeted expression of dominant negative proteasome
mutants in Drosophila melanogaster. Genesis 34:80–82.
26. Epand RM (2008) Proteins and cholesterol-rich domains. Biochim Biophys Acta
1778:1576–1582.
27. Carvalho K, Ramos L, Roy C, Picart C (2008) Giant unilamellar vesicles containing
phosphatidylinositol(4,5)bisphosphate: Characterization and functionality. Biophys J
95:4348–4360.
28. Cremesti AE, Goni FM, Kolesnick R (2002) Role of sphingomyelinase and ceramide in
modulating rafts: Do biophysical properties determine biologic outcome? FEBS Lett
531:47–53.
29. Huang J, Feigenson GW (1999) A microscopic interaction model of maximum solubility
of cholesterol in lipid bilayers. Biophys J 76:2142–2157.
30. Levental I, Janmey PA, Cebers A (2008) Electrostatic contribution to the surface pressure of
charged monolayers containing polyphosphoinositides. Biophys J 95:1199–1205.
31. Tong J, et al. (2008) Role of GAP-43 in sequestering phosphatidylinositol 4,5-
bisphosphate to Raft bilayers. Biophys J 94:125–133.
32. Chiantia S, Kahya N, Ries J, Schwille P (2006) Effects of ceramide on liquid-ordered
domains investigated by simultaneous AFM and FCS. Biophys J 90:4500–4508.
33. Tuson M, Marfany G, Gonzalez-Duarte R (2004) Mutation of CERKL, a novel human
ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26). Am J
Hum Genet 74:128–138.
34. Graf C, et al. (2008) Neutropenia with impaired immune response to Streptococcus
pneumoniae in ceramide kinase-deficient mice. J Immunol 180:3457–3466.
35. Mitsutake S, et al. (2007) The generation and behavioral analysis of ceramide kinase-
null mice, indicating a function in cerebellar Purkinje cells. Biochem Biophys Res
Commun 363:519–524.
20068  www.pnas.orgcgidoi10.1073pnas.0911028106 Dasgupta et al.
